- Home
- BCAB vs ACCS Comparison
BCAB vs ACCS Comparison
Compare BCAB & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- ACCS
- Stock Information
- Founded
- BCAB 2007
- ACCS 1988
- Country
- BCAB United States
- ACCS United States
- Employees
- BCAB N/A
- ACCS N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- ACCS Publishing
- Sector
- BCAB Health Care
- ACCS Consumer Discretionary
- Exchange
- BCAB Nasdaq
- ACCS Nasdaq
- Market Cap
- BCAB 40.5M
- ACCS 42.6M
- IPO Year
- BCAB 2020
- ACCS N/A
- Fundamental
- Price
- BCAB $0.76
- ACCS $9.72
- Analyst Decision
- BCAB Hold
- ACCS Strong Buy
- Analyst Count
- BCAB 3
- ACCS 1
- Target Price
- BCAB $1.00
- ACCS $14.00
- AVG Volume (30 Days)
- BCAB 1.4M
- ACCS 5.2K
- Earning Date
- BCAB 11-05-2025
- ACCS 11-11-2025
- Dividend Yield
- BCAB N/A
- ACCS N/A
- EPS Growth
- BCAB N/A
- ACCS N/A
- EPS
- BCAB N/A
- ACCS N/A
- Revenue
- BCAB $11,000,000.00
- ACCS $22,562,000.00
- Revenue This Year
- BCAB N/A
- ACCS $0.03
- Revenue Next Year
- BCAB N/A
- ACCS $11.45
- P/E Ratio
- BCAB N/A
- ACCS N/A
- Revenue Growth
- BCAB N/A
- ACCS 26.44
- 52 Week Low
- BCAB $0.24
- ACCS $7.79
- 52 Week High
- BCAB $2.53
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- BCAB 52.28
- ACCS 35.53
- Support Level
- BCAB $0.61
- ACCS $9.40
- Resistance Level
- BCAB $1.06
- ACCS $9.99
- Average True Range (ATR)
- BCAB 0.13
- ACCS 0.38
- MACD
- BCAB -0.02
- ACCS -0.03
- Stochastic Oscillator
- BCAB 32.78
- ACCS 20.16
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.